ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called HLX316 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. The study focuses on certain ovarian and rela…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 26, 2026 08:50 UTC
-
New drug HLX48 targets tough tumors in first human test
Disease control Not yet recruitingThis early-phase study tests a new drug called HLX48 in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 72 participants wil…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called HLX97 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 138 adults with certain breast…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New cancer trial aims to match treatments to Patients' unique tumor biology
Knowledge-focused Not yet recruitingThis study tests a new way to choose cancer treatments by quickly analyzing each patient's tumor and immune system using fresh samples. About 275 people with advanced solid tumors will have their treatment selected based on these detailed profiles, rather than just the cancer typ…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC